Conditions: Autism
Keywords: Autistic Disorder
Allocation:  | Intervention model: SEQUENTIAL
Enrollment: 25
Healthy volunteers: no

Brief summary:
This 8-week, prospective open-label study will investigate the effectiveness and tolerability of paliperidone ER in adolescents and young adults with autism. Hypothesis:Paliperidone Er will be well tolerated and efficacious for reducing aggression, self-injury, and irritability in adolescents and young adults.

Detailed description:

Arms:
arm 1: 8-Week Open-Label

Interventions: intervention 1: Paliperidone ER
Intervention descriptions: intervention 1: Starting dose is 3 mg per day. Can be titrated up to a maximum dose of 9 mg per day.

Protocol document: